Charles River Laboratories | CRL - L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
Agilent USD 442M 1000K 2025-09
Align Technology USD 148.89M 27.71M 2026-03
Bio-Rad Laboratories USD 929.2M 846.3M 2025-12
Bruker USD 68.2M 140.8M 2025-12
Cardinal Health USD 630M 32M 2025-12
Charles River Laboratories USD -294.1M 464.13M 2025-12
Cigna USD 1.82B 478M 2025-12
CVS Health USD 3.94B 2.58B 2026-03
Danaher USD 1.24B 138M 2026-03
Dentsply International USD -42M 105M 2026-03
Elevance Health USD 215M 1.19B 2025-12
Humana USD -1.01B 1.54B 2025-12
Illumina USD 157M 220M 2026-03
Incyte USD 343.6M 46.34M 2026-03
Intrexon USD -60.48M 27.09M 2024-06
IQVIA Holdings USD 6.22B 5.68B 2026-03
Laboratory Of America USD 8.73B 8.54B 2026-03
Lakefront Biotherapeutics EUR 13.96M 769.2M 2026-03
Lonza CHF 624M 197M 2024-12
McKesson USD 1.63B 235M 2025-12
Merck EUR 401M 886.1M 2025-12
Mettler Toledo International USD 329.07M 59.84M 2025-12
Novartis USD 3.84B 802M 2026-03
Pfizer USD 5.18B 6.82B 2026-03
Quest Diagnostics USD 334M 4M 2026-03
Revvity USD 91.56M 35.88M 2025-12
Thermo Fisher Scientific USD 2.12B 295M 2025-12
United Therapeutics USD 444M 6M 2025-12
UnitedHealth USD -720M 3.95B 2025-12
Veradigm USD 35.3M 13.95M 2022-09
Waters USD 264.18M 94.06M 2025-12
West Pharmaceutical Services USD 161.5M 8.6M 2025-12